🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a randomized, placebo-controlled, double-blind, multicenter p...
Status
Unknown
Location
Anhui Provincial Hospital
Start Date
2018-11-09
Trial ID
NCT03668496
Treatments Being Tested
The purpose of this study was to evaluate the efficacy and safety of Camrel...
Status
Unknown
Location
Cancer hospital, Chineses Academy of Medical Sciences
Start Date
2021-06-01
Trial ID
NCT04861467
Treatments Being Tested
This study aims to evaluate the efficacy and safety of camrelizumab in comb...
Status
Recruiting
Location
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Start Date
2024-03
Trial ID
NCT06313463
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of camreli...
Status
Completed
Location
Fudan University Cancer Hospital
Start Date
2020-12-09
Trial ID
NCT04613674
Treatments Being Tested
The study is being conducted to evaluate the efficacy and safety of SHR-121...
Status
Terminated
Location
Beijing Cancer Hosipital
Start Date
2021-02-01
Trial ID
NCT04619433
This study is a randomized, placebo-controlled, double-blind, multicenter p...
Status
Unknown
Location
Cancer Center of Sun-Yat Sen University (CCSYSU)
Start Date
2018-11-13
Trial ID
NCT03707509
Treatments Being Tested
This is a randomised, double-blinded, placebo-controlled, multi-center phas...
Status
Completed
Location
Cancer Center of Sun-Yat Sen University (CCSYSU)
Start Date
2018-12-03
Trial ID
NCT03691090
Treatments Being Tested
The purpose of this study is to observe and evaluate the efficacy and safet...
Status
Unknown
Location
The First Affiliated Hospital of Zhengzhou University
Start Date
2019-10
Trial ID
NCT03817658
This study is a randomized, double-blind, placebo-controlled, multi-center ...
Status
Completed
Location
Beijing Cancer Hospital
Start Date
2021-05-28
Trial ID
NCT04768075
Treatments Being Tested
This study is a randomized, double-blind, placebo-controlled, multicenter p...
Status
Enrolling By Invitation
Location
The First Affiliated Hospital of Nanjing Medical University
Start Date
2022-07-30
Trial ID
NCT06048926
Treatments Being Tested